Clinical trial
Corona-Virus-Disease 2019 (Covid-19) Antibody Responses in Cystic Fibrosis
NCT05614336 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Corona-Virus-Disease 2019 (Covid-19) Antibody Responses in Cystic Fibrosis
- Lead sponsor
- Hospices Civils de Lyon
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 15, 2022
- Completion date
- September 17, 2025
- Enrollment
- 331 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.